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Abstract 
5-Hydroxymethylcytosine and 5-formylcytosine are stable DNA base modifications generated 
from 5-methylcytosine by the ten-eleven translocation protein family that function as 
epigenetic markers. 5-Hydroxymethyluracil may also be generated from thymine by ten-eleven 
translocation enzymes. Here, we asked if these epigenetic changes accumulate in senescent 
cells, since they are thought to be inversely correlated with proliferation. Testing this in 
ERCC1-XPF-deficient cells and mice also enabled discovery if these DNA base changes are 
repaired by nucleotide excision repair. Epigenetic marks were measured in proliferating, 
quiescent and senescent wild-type and Ercc1
-/-
 primary mouse embryonic fibroblasts. The 
pattern of epigenetic marks depended more on the proliferation status of the cells than their 
DNA repair capacity. The cytosine modifications were all decreased in senescent cells 
compared to quiescent or proliferating cells, whereas 5-(hydroxymethyl)-2’-deoxyuridine was 
increased. In vivo, both 5-(hydroxymethyl)-2’-deoxyuridine and 5-(hydroxymethyl)-2’-
deoxycytidine were significantly increased in liver tissues of aged wild-type mice compared to 
young adult wild-type mice. Livers of Ercc1-deficient mice with premature senescence and 
aging had reduced level of 5-(hydroxymethyl)-2’-deoxycytidine and 5-formyl-2’-deoxycytidine 
compared to aged-matched wild-type controls. Taken together, we demonstrate for the first 
time, that 5-(hydroxymethyl)-2’-deoxycytidine is significantly reduced in senescent cells and 
tissue, potentially yielding a novel marker of senescence. 
 
 
Keywords: 5-hydroxymethylcytosine, 5-formylcytosine, 5-hydroxymethyluracil, ERCC1-XPF 
endonuclease, aging 
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Introduction 
Cytosine methylation, usually at CpG dinucleotides, is one of the most important epigenetic 
modifications and has a profound impact on gene repression, cellular identity and organismal 
fate (1). The reversion of DNA methylation (demethylation) is equally important to activate 
previously silenced genes, and mounting evidence suggests that replication-independent 
enzymatic demethylation or oxidation are important processes in the function of somatic cells 
(2). 
The most plausible mechanisms of active DNA demethylation/iterative oxidation 
involve ten-eleven translocation (TET) proteins that catalyze oxidation of 5-methylcytosine (5-
mCyt) to 5-hydroxymethylcytosine (5-hmCyt), which can be further oxidized to 5-
formylcytosine (5-fCyt) and 5-carboxycytosine (5-caCyt). In addition, there is experimental 
evidence that 5-hydroxymethyluracil (5-hmUra) may also be generated by TET enzymes from 
thymine and has epigenetic functions ((3), for review see: (4)). 
5-hmCyt is enriched in a subset of promoters and enhancers of actively transcribed 
genes (5). Moreover, all of these DNA modifications recruit proteins involved in DNA repair 
and in chromatin remodelling, as well as in transcription (3,6). ERCC1-XPF is a DNA repair 
endonuclease required for nucleotide excision repair (NER) (7), which may help remove 
modified pyrimidines. Low expression of ERCC1-XPF promotes accelerated aging of humans 
and mice (8) caused by faster accumulation of endogenous DNA damage and senescent cells 
(9). Senescent cells have been demonstrated to play a direct causal role in aging (10,11). It was 
also demonstrated that ERCC1-XPF may be involved in transcription initiation-dependent 
chromatin modification linked to DNA demethylation (12). All these observations prompted us 
to ask whether there are differences in epigenetic DNA modifications between Ercc1
-/- 
and 
wild-type (WT) cells and whether there are characteristic features of senescent cells in terms of 
epigenetic marks.  
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We measured the level of the whole spectrum of recently discovered epigenetic marks, 
i.e. 5-methyl-2’-deoxycytidine (5-mdC), 5-(hydroxymethyl)-2’-deoxycytidine (5-hmdC), 5-
formyl-2’-deoxycytidine (5-fdC), 5-carboxy-2’-deoxycytidine (5-cadC), 5-(hydroxymethyl)-2’-
deoxyuridine (5-hmdU) in: (i) replicating, quiescent (growth arrested) and senescent wild-type 
and Ercc1
-/- 
cells and (ii) in the liver of wild-type and Ercc1-deficient mice, during 
physiological and accelerated aging, respectively. To measure all of the modifications above, 
we applied a recently developed rapid, specific, and sensitive isotope-dilution automated online 
two-dimensional ultra-performance liquid chromatography with tandem mass spectrometry 
(2D-UPLC-MS/MS) (13).  
Methods 
Generation and culture of primary mouse embryonic fibroblasts (MEFs) 
Ercc1
-/-
 primary MEFs were prepared from day 13 embryos derived from crossing inbred 
C57BL/6J mice heterozygous for an Ercc1 null allele, as previously described (14). MEFs were 
simultaneously derived from WT littermate embryos for use as controls. Primary MEFs were 
cultured in a 1:1 mixture of Dulbecco’s modified Eagle’s medium and Ham’s F10 with 10% 
fetal bovine serum, non-essential amino acids and antibiotics, and incubated at 3% O2. Three 
independent MEF lines of each genotype were used for experiments. Cells from each embryo 
were split onto three dishes at passage 1 (p1). One plate was harvested at passage 2 when 75% 
confluent (P2 replicative). The second was passaged to 100% confluence then left for 48 hours 
(P2 quiescent). The third was passaged to passage 7 (p7) where it only reached 50% confluence 
(P7 senescent). Cells were harvested, washed in PBS, and snap frozen in liquid nitrogen and 
stored at -80°C until analysis. 
Animals 
Ercc1
-/Δ
 mice were generated by breeding Ercc1
+/-
 and Ercc1
+/Δ
 mice in inbred C57Bl/6J and 
FVB/n backgrounds, respectively, to create a cohort of mice that were in an f1 hybrid 
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background yet genetically identical. The mice were genotyped by PCR as previously 
described (14). WT littermates were used as controls. Aged WT mice were bred in house and 
were in the same f1 genetic background. Animal husbandry and experimental procedures were 
approved by The Scripps Research Institute Florida IACUC. 
Measurement of epigenetic marks 
DNA extraction and DNA hydrolysis to deoxynucleosides (dN) was performed using a method 
described previously (13). The 2D-UPLC–MS/MS analyses were performed as describe (13). 
Briefly, DNA hydrolysates were spiked with a mixture of internal standards in volumetric ratio 
4:1, to concentration of 50 fmols/µL of [D3]-5-hmdC, [
13
C10, 
15
N2]-5-fdC, [
13
C10, 
15
N2]-5-cadC 
and [
13
C10, 
15
N2]-5-hmdU. Chromatographic separation was performed with a Waters Acquity 
2D-UPLC system with photo-diode array detector, for the first-dimension chromatography 
(used for quantification of unmodified dN and 5-mdC), and Xevo TQ-S tandem quadrupole 
mass spectrometer for second dimension chromatography. At-column-dilution technique was 
used between first and second dimension for improving retention on the trap/transfer column. 
The columns used were: a Phenomenex Kinetex C-18 column (150 mm×2.1 mm, 1.7 µm) at 
the first dimension, a Waters X-select C18 CSH (100 mm×2.1 mm, 1.7 µm) at the second 
dimension and Waters X-select C18 CSH (30 mm×2.1 mm, 1,7 µm) as trap/transfer column. 
The chromatographic system was operated in heart-cutting mode, indicating that selected parts 
of the effluent from the first dimension were directed to trap/transfer column via 6-port valve 
switching, which served as the “injector” for the second-dimension chromatography system. 
The flow rate at the first dimension was 0.25 mL/min and the injection volume was 0.5-2 µL. 
The separation was performed with a gradient elution for 10 min using a mobile phase 0.1% 
acetate (A) and acetonitrile (B) escalating from 1-5% B over 5 min. The column was then 
washed with 30% acetonitrile and re-equilibrated with 99% A for 3.6 min. The flow rate at the 
second dimension was 0.35 mL/min. The separation was performed with a gradient elution for 
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10 min using a mobile phase 0.01% acetate (A) and methanol (B) ramping from 1-50% B over 
4 min, followed by isocratic flow of 50% B for 1.5 min then re-equilibration with 99% A until 
the next injection. All samples were analyzed in three to five technical replicates of which 
technical mean was used for further calculation. Mass spectrometric detection was performed 
using the Waters Xevo TQ-S tandem quadrupole mass spectrometer, equipped with an 
electrospray ionization source. Collision-induced dissociation was obtained using argon 6.0 at 3 
x 10
-6
 bar pressure as the collision gas. Transition patterns for all the analyzed compounds, as 
well as specific detector settings were determined using the MassLynx 4.1 Intelli-Start feature.  
RNA isolation and qPCR 
Total RNA was isolated from MEFs using RNeasy isolation kit (Qiagen, Valencia, CA). Total 
RNA was quantified using a Nanodrop spectrophotometer (Thermo Fisher, Waltham, MA) and 
1 μg of total RNA was used to generate cDNA with the Transcriptor First Strand cDNA 
synthesis kit (Roche, Basel Switzerland) according to the manufacturer’s specification. Gene 
expression changes in Gapdh, p16
Ink4a
, and p21
Cip1
 were quantified by qPCR reactions using 20 
μL reaction volumes using a StepOne thermocycler (Thermo Fisher, Waltham, MA) with input 
of 50 ng total RNA per reaction except for p16
 Ink4a
 (100 ng). Reactions were performed in 
duplicate in three separate experiments. Data was analyzed by ΔΔCt method and expression 
was normalized to Gapdh. qPCR primer sequences are listed in Supplementary Table 1. 
Immunofluorescence 
WT and Ercc1
-/-
 MEFs were cultured on glass coverslips until they reached 50% confluence. 
Cells were ﬁxed with 2% paraformaldehyde in PBS for 15 min. Cells were permeabilized with 
0.1% Triton X-100 in PBS and the phosphorylated form of γH2AX detected with monoclonal 
anti-γH2AX (05-636, Millipore, Billerica, MA) and Alexa 594-conjugated goat anti-mouse IgG 
(A-11005, Invitrogen, Carlsbad, CA) in PBS with 0.15% glycine and 0.5% bovine serum 
albumin. γH2AX foci were counted with an Olympus BX51 ﬂuorescent microscope. 
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Senescence-associated β-Galactosidase (SA-β-Gal) staining 
Frozen tissue sections and primary WT and Ercc1
-/-
 MEFs were fixed in 0.25% glutaraldehyde 
and 2% paraformaldehyde for ten min at room temperature. Following three rinses in PBS, SA-
β-Gal staining was performed as previously described (15,16). 
Immunoblotting 
Cells were trypsinized, pelleted, and the pellet was dissolved in ice-cold NETT buffer (100mM 
NaCl, 50mM Tris pH 7.5, 5mM EDTA pH 8.0, 0.5% Triton-X) with Mini-complete protease 
inhibitor tablet (11836153001, Roche Applied Science, Indianapolis, IN). Fifty μg of whole 
cell lysate was boiled in 4xloading buffer [0.25M Tris-HCl (pH 8.5), 8% SDS, 1.6mM EDTA, 
0.1M DTT, 0.04% bromophenol blue, 40% glycerol] and separated by SDS-PAGE on a 4-20% 
Mini-PROTEAN gradient gel (Bio-Rad, Hercules, CA), and transferred to nitrocellulose 
membrane. Primary antibodies against p16 (clone M-156, Santa Cruz Biotechnology, Santa 
Cruz, CA), beta-actin (ab13822, Abcam, Cambridge, MA) were used at a dilution of 1:500. 
This was followed by a 1:1000 dilution of either AP-conjugated anti-chicken IgG (ab6878, 
Abcam, Cambridge, MA) or AP-conjugated anti-rabbit IgG (S-373, Promega, Madison, WI). 
Blots were developed and imaged using the Alpha Innotech Red gel imaging system. 
Densitometry was calculated using the spot density software on the Alpha Innotech Red gel 
imaging system. 
Statistical analysis 
Statistical analysis was performed using STATISTICA version 13 (www.statsoft.com). 
Repeated-measures analysis of variance (ANOVA)-LSD test was performed to assess the 
differences in the levels of epigenetic DNA modifications. In all analyzes p<0.05 was 
considered statistically significant. The results are depicted in the graphs in the form of average 
value with standard deviation.  
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Results 
Epigenetic marks in replicative-, quiescent- and senescent cells 
5-MdC, 5-hmdC, 5-fdC, and 5-hmdU levels were measured in the genomic DNA isolated from 
replicative, quiescent and senescent cells. Replicative cells were early passage primary MEFs 
maintained at 50% confluence. Quiescent cells were early passage primary MEFs maintained at 
100% confluence without passaging. Senescent cells are late passage primary cells (p7). All 
three were derived from the same embryo and three biological replicates prepared. 
Expression of senescence markers p16
Ink4a
 and p21
Cip1
 were measured in the same cells 
used for methylated and oxidized deoxynucleosides. mRNA levels for both senescence markers 
were significantly elevated in late passage cells compared to early passage (Figure 1A). 
Furthermore, expression was elevated in Ercc1
-/-
 cells compared to WT. Deletion of Ercc1 
causes reduced expression of the DNA repair enzyme ERCC1-XPF (8), required for NER, 
interestrand crosslink repair and the repair of some double-strand breaks (17). Deficiency of 
ERCC1-XPF causes the accumulation of endogenous oxidative DNA damage in vivo (18). 
Thus, Ercc1
-/-
 cells have increased expression of senescence markers compared to WT controls. 
To confirm premature senescence in Ercc1
-/-
 MEFs compared to WT cells, additional 
markers of cellular senescence in primary MEFs serially passaged at 3% O2 or 20% O2, which 
accelerates senescence of primary MEFs in particular if DNA repair is impaired genetically 
(19). Three markers of senescence were measured in congenic wild-type and Ercc1
-/-
 MEFs at 
multiple passage numbers: γH2AX foci, SA-β-gal activity and p16 protein levels. With 
increasing passage of all four cultures, there was a significant increase in the fraction of cells 
with γH2AX foci (Figure 1B and Supplementary Figure 1). Furthermore, there was a 
significantly greater fraction of WT and Ercc1
-/-
 MEFs with γH2AX foci in cultures grown at 
20% O2 compared to 3% O2. Ercc1
-/-
 MEFs had significantly more γH2AX foci than WT MEFs 
whether grown at 20% or 3% O2. SA-β-gal activity is another hallmark feature of senescent 
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cells (15). SA-β-gal activity followed a very similar pattern as that of γH2AX foci (Figure 1C 
and Supplementary Figure 1). The fraction of cells staining positively for SA-β-gal increased 
with increasing passage number in WT and Ercc1
-/-
 MEFs, and to a greater extent in cells 
cultured at 20% O2 relative to 3%. Significantly more Ercc1
-/-
 MEFs stained positively for SA-
β-gal at each passage (3, 5 and 7) at 20% O2, but not until passage 7 if the cells were grown at 
3% O2. The fraction of cells that stained positively for SA-β-gal in any given culture was 
consistently lower than the fraction staining positively for γH2AX foci. 
At passage 3, after only 10-12 days ex vivo, the expression of p16
 
expression was 
approximately 2-fold higher in Ercc1
-/-
 MEFs compared to WT MEFs, when cultured at 3% or 
20% O2 (Figure 1D). p16
 
expression was also modestly increased in WT cells grown at 20% O2 
compared to 3%, consistent with the other senescence markers. Taken together, these results 
demonstrate that DNA repair-deficient Ercc1
-/-
 primary MEFs undergo cellular senescence 
more rapidly than congenic WT cells and therefore in our experiments there is likely an 
increased fraction of senescence cells in the Ercc1
-/-
 p7 cultures used to measure DNA 
methylation relative to WT cultures (Figure 1A and D). 
The mean value of 5-mdC in wild-type  replicative cells was 8.74/10
3
dN (SD±0.3075) 
(Figure 2A). The level of 5-mdC was not significantly different between WT replicative and 
quiescent (8.58/10
3
dN±0.2795) or senescent cells (8.24/10
3
dN±0.6610). However, it is notable 
that there was a large standard deviation in measurements of 5-mdC in WT senescent cells. 
Increased heterogeneity is typical of senescent cells (20). The level of 5-mdC was similar 
between replicative and quiescent Ercc1
-/- 
and WT fibroblasts (Figure 2A). This strongly 
suggests that 5-mdC is not repaired by NER, an ERCC1-dependent repair pathway, consistent 
with findings of others (21). The levels of 5-mdC was, however significantly lower in senescent 
Ercc1
-/-
 cells (8.07/10
3
dN±0.0661) compared to replicative (8.99/10
3
dN±0.0525) or quiescent 
(8.93/10
3
dN±0.0251) cells. This likely reflects the fact that in the Ercc1
-/-
 cells senescence 
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more rapidly than WT cells [(8) and Figure 1] and therefore may have additional epigenetic 
changes (20,22).  
For 5-hmdC, the results were more complex (Figure 2B). There was a significant-
difference in levels of 5-hmdC between WT and Ercc1
-/-
 cells in the replicative and senescent 
cell populations, but not the quiescent cells. The mutant cells had significantly higher levels of 
5-hmdC than WT cells in two of three cell populations, which may reflect an inability to repair 
these modified bases in the absence of NER. The level of 5-hmdC was similar for both 
genotypes in quiescent cells, which were 0.04/10
3
dN±0.0054 and 0.04/10
3
dN±0.0026 for the 
WT and mutant cells respectively. This is consistent with global NER being attenuated in post-
mitotic, quiescent cells (23). The highest level of 5-hmdC was observed in quiescent cells, 
while in senescent cells, the levels were at least 2-fold lower (Table 1). Levels in replicative 
cells were intermediate. This may indicate reduced TET activity in senescent cells. 
We also observed reduced levels of 5-fdC in senescent cells irrespective of genotype 
(Figure 2C). The highest level of 5-fdC was observed in replicating WT cells (mean value 
0.07/10
6
dN±0.0036). This was significantly greater than in Ercc1
-/-
 MEFs (mean value 
0.05/10
6
dN±0.0040). This may reflect the fact that Ercc1
-/-
 primary cells proliferate more 
slowly than isogenic WT cells. The levels of 5-fdC was reduced in quiescent and senescent 
cells compared to replicative, regardless of the genotype of the cells (Table 1). Therefore, the 
levels of 5-fdC appear to correlate best with ability to replicate.  
Determination of 5-hmdU revealed a significantly higher level in Ercc1
-/-
 senescent 
cells (mean value 1.14/10
6
dN±0.1165) compared to replicative and quiescent cells, with mean 
values 0.72/10
6
dN±0.2079 and 0.58/10
6
dN±0.0543, respectively (Figure 2D). There were no 
significant differences in the level of 5-fdC in WT cells of different replicative capacity (Table 
1). 5-cadC was undetectable in primary MEFs, with the limit of detection for this modification 
being a modification per 10
9
 deoxynucleosides in our assay. 
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Epigenetic marks in mouse tissues 
We previously demonstrated that several markers of senescence are more apparent in Ercc1
-/Δ
 
mice compared to age-matched littermates (9). This includes reduced hepatocyte proliferation 
(reduced Ki67 staining post-partial hepatectomy), increased SA-β-gal staining and increased 
lipofuscin. The same markers are more apparent in livers of aged WT mice compared to young 
adult animals (9). Hence, we focused on liver for measurement of epigenetic marks. 
The profile of epigenetics marks was estimated in DNA isolated from livers of 10-, 15- 
and 130-week-old WT mice, as well as 10- and 15-week-old DNA-deficient progeroid Ercc1
-/Δ
 
mice. The level of 5-mdC was similar in livers of WT mice at all ages (Table 2, Figure 3A). We 
did not find any significant genotype-specific or age-related differences in the level of 5-mdC 
in liver tissue.  
In contrast, the level of 5-hmdC increased significantly with aging in WT mice (Figure 
3B), from 0.34/10
3
dN±0.0175 to 0.78/10
3
dN±0.0058 respectively with p<0.00001. 5-hmdC 
levels were 1.5 fold higher in 10- and 15-week-old WT mouse liver compared to age-matched 
Ercc1
-/Δ
 mice (Table 2). Nevertheless, there was a significant increase in the level of 5-hmdC in 
liver of Ercc1
-/Δ 
from 10 to 15 weeks of age, reflecting an age-related increase, similar to WT 
mice, albeit more accelerated. 
5-FdC was detected in all liver tissues analyzed (Figure 3C). There was no significant 
change in 5-fdC levels in WT mice with aging. However, there was a significant increase in 
Ercc1
-/Δ
 mice between 10-15 weeks of age (Table 2). Levels of 5-fdC were significantly lower 
(~1.6-fold) in Ercc1
-/Δ
 mice, compared to WT mice at both ages of mice. 
There was no statistically significant difference in the 5-cadC level among 10- ,15- and 
130-week-old WT and Ercc1
-/Δ 
mice (Table 2, Figure 3D). The levels 5-hmdU in DNA from 10 
week old WT mouse liver reached the value of 0.21/10
6
dN±0.027 (Figure 3E). The level 
increased significantly to 0.37/10
6
dN±0.038) in old WT mice. There was no significant 
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difference in 5-hmdU levels between WT and DNA repair- deficient mice at any age tested 
(Table 2).  
Discussion 
Fundamental mechanisms that drive aging are poorly understood (reviewed in (24)). However, 
it is abundantly clear that damaged, senescent cells accumulate as organisms age (16,25-28). 
Recent studies demonstrate that the clearance of senescent cells in aged mice improves 
healthspan, thereby establishing that senescence drives multiple age-related pathologies 
(10,29,30). 
Senescence is an irreversible cell cycle arrest that occurs in response to cellular stress 
(31). Senescence is a genetically programmed tumor suppressor mechanism. DNA damage, 
which drives mutation accumulation in replicating cells, is a potent driver of senescence (32). 
Senescent cells remain metabolically active and secrete numerous cytokines, chemokines and 
matrix remodeling enzymes. Thus, gene expression patterns are altered in senescent cells. Here, 
we sought to determine if globally, epigenetic changes to DNA are altered in senescent cells by 
measuring modified pyrimidines in senescent cells compared to quiescent cells in which the 
cell cycle is reversibly arrested. Late passage, senescent cells had increased expression of p16, 
increased γH2AX foci, and increased SA-β-Gal activity compared to early passage cells 
(Figure 1) and this was even more exaggerated in DNA repair deficient Ercc1
-/-
 cells. 
Generally speaking, replicative and quiescent cells were more similar to one another than to 
senescent cells (Table 1). 5-mdC, 5-hmdC and 5-fdC tended to be lower in senescent cells than 
non-irreversibly arrested cells, while 5-hmdU tended to be higher. This is consistent with and 
extends previous work indicating that 5-mdC levels are decreased in senescent or late passage 
mammalian cells (22,33). Notably, none of the modified pyrimidines were consistently 
increased in ERCC1-XPF deficient cells and tissue. Hence, there is no reason to believe that 
any of these modified nucleosides are removed from the genome by nucleotide excision repair. 
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Recently it was demonstrated that 5-hmCyt is a relatively stable DNA modification and 
that levels of this modification differ dramatically between various tissues in the mouse, with 
proliferative tissues having the lowest levels (34,35). In agreement with this, we found that 
proliferating cells had significantly decreased 5-hmdC compared to quiescent cells (Figure 2B). 
Intriguingly, the level of 5-hmdC was also 4-fold lower in senescent WT cells compared to 
quiescent cells. This was replicated in Ercc1
-/-
 primary MEFs, suggesting that low levels of 5-
hmdC might be a consistent hallmark of senescent cells. 
Because of the close ties between senescence and aging (36), we also measured these 
epigenetic marks in tissues from aged WT and progeroid Ercc1-deficient
 
mice, using liver, 
where senescent cells accumulate as organisms age, as documented by reduced proliferative 
capacity, increased SA-β-Gal activity, lipofuscin and expression of p16Ink4a (9). In vivo, 5-mdC 
and 5-fdC levels did not change with normal aging (Table 2 and Figure 3C), as previously 
reported for mouse kidney and brain (37). In contrast, 5-hmdC and 5-hmdU were significantly 
increased in liver of old mice (Figure 3B and E). This is in agreement with a previous study 
demonstrating an increase in 5-hmdC in brain and kidney of mice with age (37). In contrast, in 
Ercc1-deficient mice, 5-hmdC levels were 1.5-fold lower than age-matched WT mice and 3-
fold lower than old WT mice (Figure 3B), which is in keeping with our observation that 5-
hmdC is decreased in senescent cells. The difference between the progeroid Ercc1
-/Δ 
and aged 
WT mice could reflect the fact that there is significantly more oxidative DNA damage in liver 
of Ercc1
-/Δ 
mice  than old WT mice (18), which is a potent driver of cellular senescence (36). 
Alternatively, Ercc1
-/Δ
 mice display hypercholesterolemia and low triglycerides, while old WT 
mice do not (9). Thus, it is possible that metabolic differences dictate the differences in 5-
hmdC levels between the progeroid and naturally aged mice. Interestingly, decreased levels of 
5-hmdC and TET1 expression was recently reported in Down syndrome, which is characterized 
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by premature aging and senescence (38). Similarly, Xiong et al., reported a significant decline 
in 5-hmdC levels in human peripheral blood cells with age (39).  
It is becoming increasingly clear that the product of 5-mdC oxidation (5-hmdC) may act 
as an intermediate of active DNA demethylation and play a regulatory role, e.g. controlling the 
transition between different cell states (40) by bind gene regulatory proteins (41). Therefore, a 
decrease in this modification in senescent cells may be one of the factors responsible for 
perturbation of cellular metabolism. It is noteworthy that TET proteins preferentially bind 
transcription start sites (42), and 5-hmCyt enrichment is found at promoters and enhancers of 
actively transcribed genes (5,43). 
Several recent studies demonstrate that 5-hmCyt is reduced in many types of human 
malignancies compared to non-malignant tissue (44,45). Interestingly, senescent cells share 
many things in common with cancer cells, including alteration in gene expression that favors 
cell survival (29,30,46). 
 It is unclear why 5-hmCyt is decreased in cancer and in senescent cells. There are 
several metabolites, including intermediates of the TCA cycle 2-OH-glutarate, succinate and 
fumarate that inhibit 2-ketoglutarate-dependent dioxygenases, among them the TET enzymes 
(47). These metabolites may accumulate as a result of metabolic changes that accompany 
cellular senescence (48). The low levels of 5-hmdC in senescent cells and tissues of mice with 
a high burden of senescent cells strengthens the similarity between senescent and malignant 
cells, and may serve as a marker of irreversibly damaged cells.  
Supplementary Material 
Supplementary data is available at The Journals of Gerontology, series A: Biological Sciences 
and Medical Sciences online. 
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Table 1. The level of epigenetic marks, 5-mdC, 5-hmdC, 5-fdC, as well as 5-hmdU in MEFs, 
WT and Ercc1
-/-
. The data are shown as mean±SD.  
Cells 
Genotype WT Ercc1
-/-
 
Cell type Replicative Quiescent Senescent Replicative Quiescent Senescent 
5-mdC/10
3
dN 8.74±0.3075 8.58±0.2795 8.24±0.6610 8.99±0.0525 8.93±0.0251 8.07±0.0661 
5-hmdC/10
3
dN 0.02±0.0016 0.04±0.0054 0.011±0.0004 0.03±0.0030 0.04±0.0026 0.015±0.0023 
5-fdC/10
6
dN 0.07±0.0036 0.05±0.0227 0.03±0.0132 0.05±0.0040 0.05±0.0075 0.03±0.0109 
5-hmdU/10
6
dN 1.52±1.1749 0.91±0.2588 1.04±0.2098 0.72±0.2079 0.58±0.0543 1.14±0.1165 
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Table 2. The level of epigenetic marks, 5-mdC, 5-hmdC, 5-fdC, 5-cadC as well as 5-hmdU in 
WT and Ercc1
-/∆
 livers. The data are shown as mean±SD. 
Tissues (livers) 
Genotype WT Ercc1
-/∆
 
Age (weeks) 10 15 130 10 15 
5-mdC/10
3
dN 7.97±0.1836 8.05±0.2240 8.06±0.0346 8.32±0.1709 8.51±0.1688 
5-hmdC/10
3
dN 0.34±0.0175 0.40±0.0162 0.78±0.0058 0.23±0.0072 0.28±0.0055 
5-fdC/10
6
dN 0.22±0.0308 0.23±0.0442 0.24±0.0366 0.14±0.0249 0.19±0.0332 
5-cadC/10
9
dN 5.14±1.0544 5.10±1.3454 4.08±0.9828 3.99±0.8700 4.12±1.2805 
5-hmdU/10
6
dN 0.21±0.0274 0.26±0.0240 0.37±0.0378 0.27±0.0381 0.23±0.0219 
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Figure 1. DNA repair deficiency promotes cellular senescence  
(A) Quantification of expression of senescence markers p16
INK4a
 and p21
Cip1
 mRNA in MEF 
cultures used for analysis of epigenetic markers.  
(B) Quantification of γH2AX foci in WT and Ercc1-/- MEFs at passages 3, 5 and 7 grown at 3% 
or 20% O2. Cells were fixed and immunostained for γH2AX foci. Ten random fields were 
analyzed for each cell line and the fraction of cells with foci determined. The average from 3 
independent cell lines is plotted on the graph. Error bars represent ±S.E.M. Asterisk indicates 
significance using a two tailed Student's t-test where p<0.05. 
(C) Quantification of SA-β-Gal positive cells in WT and Ercc1-/- MEF cultures at passage 3, 5 
and 7 grown at 3% or 20% O2.  Cells were fixed and stained with X-gal. Ten random fields of 
view were analyzed for each cell line and the percent of 100-300 cells staining positively for 
SA-β-Gal determined. The average of 3 independent cell lines is plotted on the graph. Error 
bars represent the S.E.M. Asterisk indicates significance using a two tailed Student's t-test 
where p<0.05. 
(D) Immunoblot detection of the senescence marker p16
INK4a
 in passage 3 WT and Ercc1
-/-
 
MEFs cultured at 3% or 20% oxygen. β-actin was used as a loading control to calculate the 
fold-increase in p16 expression relative to WT cells cultured at 3% O2. 
Figure 2. Levels of epigenetic marks in DNA from replicative, quiescent and senescent 
primary mouse embryonic fibroblasts (MEFs).  
(A) Level of 5-mdC.  
(B) Level of 5-hmdC.  
(C) Level of 5-fdC.  
(D) Level of 5-hmdU. 
Figure 3. Levels of epigenetic marks in livers DNA of 10-, 15- 130 weeks mice.  
(A) Level of 5-mdC.  
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(B) Level of 5-hmdC.  
(C) Level of 5-fdC.  
(D) Level of 5-cadC.  
(E) Level of 5-hmdU. 
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Figure 1. 
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Figure 3. 
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